“『 yeotop3.com 』 여탑◈눈부신◈수색동안마☄수색동마사지➨수색동풀싸롱❈수색동키스방い수색동건마➹수색동휴게텔っ수색동스파”的搜索结果，显示 381-390 项，共有 12428 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) wild type ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... I of the study. Also, to evaluate the feasibility of molecular characterization based on TMB and gene expression profiling (GEP) (for TIS - tumor ...

4. 内分泌科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to (i)assess glucose variability at pre specified time points after Pancreas Transplantation (ii) collect pre- ...

5. 肺科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the dose escalation and expansion of RP1 alone and combined with nivolumab in adult subjects with advanced and/or ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) wild type ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...